Form4insider filings, from the source

SEC Form 4 · accession 0001140361-15-043414

OncoMed Pharmaceuticals Inc · OMED

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Nov 30, 2015
Accepted (ET)
Dec 2, 2015 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001302573

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Nov 30, 2015J39,017$0.00A125,060IBy Adams Street Partnership Fund - 2002 U.S. Fund, L.P.
Common StockF3Nov 30, 2015J18,277$0.00A54,833IBy Adams Street Partnership Fund - 2003 U.S. Fund, L.P.
Common StockF4Nov 30, 2015J14,118$0.00A42,355IBy Adams Street Partnership Fund - 2004 U.S. Fund, L.P.
Common StockF5Nov 30, 2015J19,666$0.00A59,000IBy Adams Street Partnership Fund - 2005 U.S. Fund, L.P.
Common StockF6Nov 30, 2015J1,166$0.00A3,498IBy Brinson Partnership Fund-2004 Primary Fund, L.P.
Common StockF7Nov 30, 2015J782$0.00A2,346IBy The 2004 Primary Brinson Partnership Fund Offshore Series Company Ltd.
Common StockF8Nov 30, 2015J2,431$0.00A7,294IBy UBS Global Asset Management Trust Company as Trustee of the Brinson Partnership Fund Trust- 2004
Common StockF9Nov 30, 2015J24,631$0.00A82,395IBy The Bank of New York Mellon as Trustee for the Hewlett-Packard Company Master Trust
Common StockF10Nov 30, 2015J9,205$0.00A37,591IBy Brinson Partnership Fund-2001 Primary Fund, L.P.
Common StockF11Nov 30, 2015J7,026$0.00A28,691IBy The 2001 Primary Brinson Partnership Fund Offshore Series Company Ltd.
Common StockF12Nov 30, 2015J22,125$0.00A90,349IBy UBS Global Asset Management Trust Company as Trustee of the Brinson Partnership Fund Trust- 2001
Common StockF13Nov 30, 2015J2,939$0.00A12,046IBy Orange County Employees Retirement System
Common StockF14Nov 30, 2015J14,695$0.00A59,567IBy State Universities Retirement System Private Trust I
Common StockF15holding———641,750IBy Adams Street 2006 Direct Fund, L.P.
Common StockF16holding———592,953IBy Adams Street V, L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses